Cargando…
Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines
Oral vaccination has the potential to offer a safer and more efficacious approach for protection against enteric pathogens than injection-based approaches, especially in developing countries. One key advantage is the potential to induce intestinal immune responses in addition to systemic immunity. I...
Autores principales: | Albutti, Aqel, Longet, Stephanie, McEntee, Craig P., Quinn, Shauna, Liddicoat, Alex, Rîmniceanu, Cristiana, Lycke, Nils, Lynch, Lydia, Cardell, Susanna, Lavelle, Ed C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230052/ https://www.ncbi.nlm.nih.gov/pubmed/34201310 http://dx.doi.org/10.3390/vaccines9060619 |
Ejemplares similares
-
Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines
por: Davitt, Christopher J. H., et al.
Publicado: (2019) -
Liver sulfatide-reactive type II NKT cells recognize endogenous phospholipids
por: Kato, Shingo, et al.
Publicado: (2014) -
Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis
por: Sebode, Marcial, et al.
Publicado: (2019) -
Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation
por: McEntee, Craig P., et al.
Publicado: (2019) -
Prevention of Autoimmunity by Targeting a Distinct, Noninvariant CD1d-reactive T Cell Population Reactive to Sulfatide
por: Jahng, Alex, et al.
Publicado: (2004)